Atorvastatin and Simvastatin Promoted Mouse Lung Repair After Cigarette Smoke-Induced Emphysema
暂无分享,去创建一个
W. Zin | L. C. Pôrto | S. Valença | G. Carvalho | Manuella Lanzetti | I. Cattani-Cavalieri | Emanuel Kennedy-Feitosa | V. Pinho-Ribeiro | L. B. Gitirana | M. V. Barroso | Adriane Graça-Reis | Adriana Correa Melo
[1] M. Boskabady,et al. Evaluation of Simvastatin and Bone Marrow-Derived Mesenchymal Stem Cell Combination Therapy on Airway Remodeling in a Mouse Asthma Model , 2016, Lung.
[2] S. Uh,et al. Attenuation of Cigarette Smoke-Induced Emphysema in Mice by Apolipoprotein A-1 Overexpression. , 2015, American journal of respiratory cell and molecular biology.
[3] Haigang Song,et al. Long-term administration of simvastatin reduces ventilator-induced lung injury and upregulates heme oxygenase 1 expression in a rat model. , 2015, The Journal of surgical research.
[4] Zhiyong Ji,et al. Atorvastatin attenuates inflammation and oxidative stress induced by ischemia/reperfusion in rat heart via the Nrf2 transcription factor. , 2015, International journal of clinical and experimental medicine.
[5] D. Attar-Zadeh. Smoking cessation and COPD: a case study , 2014 .
[6] L. C. Pôrto,et al. Oxidative Stress and Inflammation Are Differentially Affected by Atorvastatin, Pravastatin, Rosuvastatin, and Simvastatin on Lungs from Mice Exposed to Cigarette Smoke , 2014, Inflammation.
[7] V. Lagente,et al. Roflumilast N-Oxide Prevents Cytokine Secretion Induced by Cigarette Smoke Combined with LPS through JAK/STAT and ERK1/2 Inhibition in Airway Epithelial Cells , 2014, PloS one.
[8] A. Ma,et al. Atorvastatin Attenuates Bleomycin-Induced Pulmonary Fibrosis via Suppressing iNOS Expression and the CTGF (CCN2)/ERK Signaling Pathway , 2013, International journal of molecular sciences.
[9] Q. Hamid,et al. IL-8 production in response to cigarette smoke is decreased in epithelial cells from COPD patients. , 2013, Pulmonary pharmacology & therapeutics.
[10] W. Zin,et al. Redox markers and inflammation are differentially affected by atorvastatin, pravastatin or simvastatin administered before endotoxin-induced acute lung injury. , 2013, International immunopharmacology.
[11] P. Delvenne,et al. Proinflammatory cytokines induce bronchial hyperplasia and squamous metaplasia in smokers: implications for chronic obstructive pulmonary disease therapy. , 2012, American journal of respiratory cell and molecular biology.
[12] Jun-xia Jiang,et al. Simvastatin delivery via inhalation attenuates airway inflammation in a murine model of asthma. , 2012, International immunopharmacology.
[13] W. Zin,et al. Long-term exposure to cigarette smoke impairs lung function and increases HMGB-1 expression in mice , 2011, Respiratory Physiology & Neurobiology.
[14] D. Sin,et al. Everything prevents emphysema: are animal models of cigarette smoke-induced chronic obstructive pulmonary disease any use? , 2011, American journal of respiratory cell and molecular biology.
[15] Elena S. Peterson,et al. Smoking, COPD, and 3-Nitrotyrosine Levels of Plasma Proteins , 2011, Environmental health perspectives.
[16] B. Make,et al. Identifying and characterizing COPD patients in US managed care. A retrospective, cross-sectional analysis of administrative claims data , 2011, BMC health services research.
[17] A. Churg,et al. Animal models of cigarette smoke-induced chronic obstructive pulmonary disease , 2010, Expert review of respiratory medicine.
[18] Christopher S. Stevenson,et al. Pharmacological characterisation of anti-inflammatory compounds in acute and chronic mouse models of cigarette smoke-induced inflammation , 2010, Respiratory research.
[19] N Roche,et al. Treatment of COPD: from pharmacological to instrumental therapies , 2010, European Respiratory Review.
[20] S. Mañes,et al. Immunomodulatory and anti-inflammatory activities of statins. , 2009, Endocrine, metabolic & immune disorders drug targets.
[21] R. Radi,et al. Superoxide-mediated inactivation of nitric oxide and peroxynitrite formation by tobacco smoke in vascular endothelium: studies in cultured cells and smokers. , 2009, American journal of physiology. Heart and circulatory physiology.
[22] A. Churg,et al. The role of interleukin-1beta in murine cigarette smoke-induced emphysema and small airway remodeling. , 2009, American journal of respiratory cell and molecular biology.
[23] W. Mazur,et al. Comparison of 8-Isoprostane and Interleukin-8 in Induced Sputum and Exhaled Breath Condensate from Asymptomatic and Symptomatic Smokers , 2009, Respiration.
[24] Samuel Santos Valença,et al. Estudo imunohistoquímico do remodelamento pulmonar em camundongos expostos à fumaça de cigarro , 2008 .
[25] A. Papavassiliou,et al. Simvastatin activates Keap1/Nrf2 signaling in rat liver , 2008, Journal of Molecular Medicine.
[26] L. C. Pôrto,et al. Supplementation with vitamins C and E improves mouse lung repair. , 2008, The Journal of nutritional biochemistry.
[27] C. Le Quément,et al. The selective MMP‐12 inhibitor, AS111793 reduces airway inflammation in mice exposed to cigarette smoke , 2008, British journal of pharmacology.
[28] Y. Nasuhara,et al. Decreased Airway Expression of Vascular Endothelial Growth Factor in Cigarette Smoke-Induced Emphysema in Mice and COPD Patients , 2008, Inhalation toxicology.
[29] I. Rahman,et al. Redox regulation of lung inflammation: role of NADPH oxidase and NF-kappaB signalling. , 2007, Biochemical Society transactions.
[30] R. Tkacova,et al. Systemic inflammation and systemic oxidative stress in patients with acute exacerbations of COPD. , 2007, Respiratory medicine.
[31] Irfan Rahman,et al. Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling method , 2006, Nature Protocols.
[32] J. V. Bannister,et al. Assays for superoxide dismutase. , 2006, Methods of biochemical analysis.
[33] Y. Cha,et al. A Quantitative Nitroblue Tetrazolium Assay for Determining Intracellular Superoxide Anion Production in Phagocytic Cells , 2006, Journal of immunoassay & immunochemistry.
[34] P. Ridker,et al. Anti-Inflammatory Effects of Statins: Clinical Evidence and Basic Mechanisms , 2005, Nature Reviews Drug Discovery.
[35] B. Make,et al. Treatments for COPD. , 2005, Respiratory medicine.
[36] T. Mariani,et al. Induction of macrophage elastase (MMP‐12) gene expression by statins , 2005, Journal of cellular physiology.
[37] S. Costi,et al. Rehabilitation of COPD patients: which training modality. , 2004, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.
[38] L. C. Pôrto,et al. Inhibition of interleukin-1beta reduces mouse lung inflammation induced by exposure to cigarette smoke. , 2004, European journal of pharmacology.
[39] S. Valença,et al. Emphysema and Metalloelastase Expression in Mouse Lung Induced by Cigarette Smoke , 2004, Toxicologic pathology.
[40] A. M. Houghton,et al. Neutrophil elastase contributes to cigarette smoke-induced emphysema in mice. , 2003, The American journal of pathology.
[41] Konstantinos Kostikas,et al. Oxidative stress in expired breath condensate of patients with COPD. , 2003, Chest.
[42] R. Bouhafs,et al. Lipid Peroxidation of Lung Surfactant due to Reactive Oxygen Species Released from Phagocytes Stimulated by Bacteria from Children with Cystic Fibrosis , 2003, Free radical research.
[43] S. Hammerschmidt,et al. Tissue lipid peroxidation and reduced glutathione depletion in hypochlorite-induced lung injury. , 2002, Chest.
[44] A. Turman,et al. Respiratory-related neuronal activity in the nucleus ambiguus-retroambigualis complex and their responses to peripheral and central stimulation in the rat , 2001, Respiratory Research.
[45] S. Shapiro,et al. Matrix metalloproteinases in lung biology , 2000, Respiratory research.
[46] D. Postma,et al. Ongoing airway inflammation in patients with COPD who do not currently smoke. , 2000, Thorax.
[47] R. Puntoni,et al. Plasma 3-nitrotyrosine in cigarette smokers. , 1997, American journal of respiratory and critical care medicine.
[48] K. Hirata,et al. Role of endogenous nitric oxide in airflow obstruction in smokers. , 1996, Chest.
[49] L. Lewis. Statins, cholesterol, and mevalonate pathways? , 1996, The Lancet.
[50] W M Thurlbeck,et al. Emphysema: definition, imaging, and quantification. , 1994, AJR. American journal of roentgenology.
[51] W. Pryor,et al. Oxidants in Cigarette Smoke Radicals, Hydrogen Peroxide, Peroxynitrate, and Peroxynitrite a , 1993, Annals of the New York Academy of Sciences.
[52] G. Böhm,et al. A comparison between the isovolume and the end‐inflation occlusion methods for measurement of lung mechanics in rats , 1991, Journal of applied toxicology : JAT.
[53] S. Sasagawa,et al. Assay method for myeloperoxidase in human polymorphonuclear leukocytes. , 1983, Analytical biochemistry.
[54] E. Weibel,et al. PRACTICAL STEREOLOGICAL METHODS FOR MORPHOMETRIC CYTOLOGY , 1966, The Journal of cell biology.
[55] W. Zin,et al. The influence of 5-lipoxygenase on cigarette smoke-induced emphysema in mice. , 2014, Biochimica et biophysica acta.
[56] 杨士芳. Feasibility of 8-OHdG formation and hOGG1 induction in PBMCs for assessing oxidative DNA damage in the lung of COPD patients. , 2014 .
[57] D. Sin,et al. Statin reverses smoke-induced pulmonary hypertension and prevents emphysema but not airway remodeling. , 2011, American journal of respiratory and critical care medicine.
[58] L. C. Pôrto,et al. Immunohistochemical study of lung remodeling in mice exposed to cigarette smoke*. , 2008, Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia.
[59] R. Tkacova,et al. The association between oxidative stress and obstructive lung impairment in patients with COPD. , 2007, Physiological research.
[60] B. Willemse. Smoking cessation in chronic obstructive pulmonary disease , 2005 .
[61] H. H. Draper,et al. Malondialdehyde determination as index of lipid peroxidation. , 1990, Methods in enzymology.
[62] H. Aebi,et al. Catalase in vitro. , 1984, Methods in enzymology.